Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -194,119 | -111,178 | -41,764 | -268,113 | -213,349 |
| Depreciation Amortization | 1,884 | 1,252 | 665 | 3,037 | 2,385 |
| Accounts receivable | N/A | N/A | N/A | 1,000 | -4,000 |
| Accounts payable and accrued liabilities | 3,426 | -2,765 | -5,123 | 4,308 | -1,286 |
| Other Working Capital | -8,534 | -18,685 | -21,110 | 38,198 | 5,426 |
| Other Operating Activity | 37,930 | 30,843 | 15,796 | 25,115 | 27,750 |
| Operating Cash Flow | $-159,413 | $-100,533 | $-51,536 | $-196,455 | $-183,074 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -373,976 | -186,407 | -147,781 | -252,323 | -197,650 |
| PPE Investments | -1,542 | -304 | -113 | -1,864 | -1,564 |
| Sale Of Investment | 250,293 | 170,529 | 95,304 | 394,730 | 294,619 |
| Purchase Sale Intangibles | -5,000 | -5,000 | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | -5,000 | 0 | 0 | -1,589 |
| Investing Cash Flow | $-130,225 | $-21,182 | $-52,590 | $140,543 | $93,816 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 48,000 | 48,000 | 48,000 | 50,000 | N/A |
| Common Stock Issued | 398,115 | 9,623 | 3,847 | 1,441 | 1,673 |
| Other Financing Activity | -944 | -557 | -536 | 6,300 | -242 |
| Financing Cash Flow | $445,171 | $57,066 | $51,311 | $57,741 | $1,431 |
| Beginning Cash Position | 188,658 | 188,658 | 188,658 | 186,829 | 186,488 |
| End Cash Position | 344,191 | 124,009 | 135,843 | 188,658 | 98,661 |
| Net Cash Flow | $155,533 | $-64,649 | $-52,815 | $1,829 | $-87,827 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159,413 | -100,533 | -51,536 | -196,455 | -183,074 |
| Capital Expenditure | -1,542 | -304 | -113 | -1,864 | -1,564 |
| Free Cash Flow | -160,955 | -100,837 | -51,649 | -198,319 | -184,638 |